Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Electronic Nicotine Delivery Systems | 17 | 2021 | 561 | 6.33 | Why? |
| Smoking Cessation | 8 | 2018 | 826 | 2.35 | Why? |
| Tobacco Products | 5 | 2019 | 245 | 2.35 | Why? |
| Vaping | 4 | 2018 | 436 | 1.76 | Why? |
| Smoking | 10 | 2020 | 3358 | 1.73 | Why? |
| Nicotine | 6 | 2020 | 213 | 1.68 | Why? |
| Tobacco Industry | 2 | 2019 | 45 | 1.41 | Why? |
| Smoking Prevention | 3 | 2018 | 116 | 1.28 | Why? |
| Asthma | 8 | 2018 | 4383 | 0.86 | Why? |
| Rhinitis, Allergic | 2 | 2018 | 704 | 0.85 | Why? |
| Lung Diseases, Interstitial | 4 | 2017 | 1476 | 0.81 | Why? |
| Tobacco | 3 | 2019 | 274 | 0.80 | Why? |
| Androstadienes | 2 | 2013 | 27 | 0.79 | Why? |
| Pulmonary Disease, Chronic Obstructive | 5 | 2018 | 3832 | 0.79 | Why? |
| Smoking Devices | 1 | 2018 | 3 | 0.78 | Why? |
| Polymyositis | 2 | 2008 | 25 | 0.75 | Why? |
| Phosphoric Diester Hydrolases | 1 | 2018 | 52 | 0.73 | Why? |
| Pyrophosphatases | 1 | 2018 | 39 | 0.72 | Why? |
| Basophils | 1 | 2018 | 179 | 0.69 | Why? |
| Sublingual Immunotherapy | 1 | 2018 | 88 | 0.69 | Why? |
| Carbon Monoxide | 1 | 2018 | 167 | 0.66 | Why? |
| Consumer Product Safety | 1 | 2017 | 57 | 0.66 | Why? |
| Smokers | 2 | 2018 | 550 | 0.61 | Why? |
| Endothelial Progenitor Cells | 1 | 2016 | 103 | 0.60 | Why? |
| Tobacco Use | 1 | 2018 | 340 | 0.57 | Why? |
| Connective Tissue Diseases | 1 | 2017 | 187 | 0.56 | Why? |
| Biological Factors | 1 | 2017 | 276 | 0.54 | Why? |
| Aerosols | 2 | 2021 | 5393 | 0.52 | Why? |
| Smoke | 1 | 2017 | 349 | 0.52 | Why? |
| Cigarette Smoking | 1 | 2017 | 337 | 0.51 | Why? |
| Weight Gain | 1 | 2018 | 552 | 0.49 | Why? |
| Desensitization, Immunologic | 1 | 2018 | 574 | 0.48 | Why? |
| Anti-Asthmatic Agents | 3 | 2018 | 427 | 0.47 | Why? |
| Respiratory Tract Diseases | 1 | 2019 | 1061 | 0.43 | Why? |
| Risk Reduction Behavior | 1 | 2017 | 946 | 0.40 | Why? |
| Th2 Cells | 1 | 2013 | 680 | 0.40 | Why? |
| Bronchial Hyperreactivity | 2 | 2013 | 38 | 0.39 | Why? |
| Histidine-tRNA Ligase | 1 | 2008 | 4 | 0.39 | Why? |
| Biological Therapy | 1 | 2013 | 456 | 0.38 | Why? |
| Harm Reduction | 3 | 2017 | 392 | 0.37 | Why? |
| Drug Delivery Systems | 1 | 2017 | 1365 | 0.34 | Why? |
| Leukotriene Antagonists | 1 | 2007 | 37 | 0.32 | Why? |
| Spirometry | 2 | 2018 | 524 | 0.28 | Why? |
| Ultrasonography | 2 | 2017 | 4409 | 0.26 | Why? |
| Cross-Over Studies | 2 | 2018 | 867 | 0.24 | Why? |
| Tobacco Smoke Pollution | 2 | 2019 | 181 | 0.24 | Why? |
| Administration, Inhalation | 3 | 2018 | 1647 | 0.24 | Why? |
| Body Weight | 2 | 2018 | 1074 | 0.23 | Why? |
| Adenosine Monophosphate | 2 | 2013 | 5652 | 0.22 | Why? |
| Rheumatic Diseases | 1 | 2017 | 2675 | 0.22 | Why? |
| Cell Phone Use | 1 | 2021 | 106 | 0.20 | Why? |
| Prednisone | 2 | 2008 | 652 | 0.19 | Why? |
| Fluticasone | 2 | 2013 | 65 | 0.19 | Why? |
| Parietaria | 1 | 2018 | 2 | 0.19 | Why? |
| Tetraspanin 30 | 1 | 2018 | 9 | 0.19 | Why? |
| Antibodies, Anti-Idiotypic | 1 | 2017 | 93 | 0.17 | Why? |
| Interleukin-5 | 1 | 2017 | 138 | 0.17 | Why? |
| Humans | 38 | 2021 | 930598 | 0.17 | Why? |
| Autoantibodies | 1 | 2008 | 2094 | 0.16 | Why? |
| Biomedical Research | 1 | 2017 | 5270 | 0.16 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.16 | Why? |
| Health Policy | 1 | 2017 | 6242 | 0.16 | Why? |
| Anti-Inflammatory Agents | 3 | 2017 | 6153 | 0.16 | Why? |
| Omalizumab | 1 | 2017 | 158 | 0.15 | Why? |
| Walk Test | 1 | 2018 | 461 | 0.15 | Why? |
| Public Health | 2 | 2019 | 16359 | 0.14 | Why? |
| Inhalation Exposure | 1 | 2019 | 405 | 0.14 | Why? |
| Exhalation | 1 | 2018 | 441 | 0.14 | Why? |
| Lung | 3 | 2017 | 31049 | 0.14 | Why? |
| Biosimilar Pharmaceuticals | 1 | 2017 | 205 | 0.14 | Why? |
| Breath Tests | 1 | 2017 | 338 | 0.14 | Why? |
| Methacholine Chloride | 1 | 2013 | 14 | 0.13 | Why? |
| MEDLINE | 1 | 2013 | 76 | 0.13 | Why? |
| Arthritis, Rheumatoid | 2 | 2017 | 2043 | 0.13 | Why? |
| Peer Review, Research | 1 | 2017 | 407 | 0.13 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Infliximab | 1 | 2017 | 502 | 0.12 | Why? |
| Allergens | 1 | 2018 | 728 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2016 | 1444 | 0.11 | Why? |
| Mexico | 1 | 2019 | 2787 | 0.11 | Why? |
| Air Pollution, Indoor | 1 | 2019 | 816 | 0.10 | Why? |
| Hot Temperature | 1 | 2017 | 1299 | 0.10 | Why? |
| Smartphone | 1 | 2021 | 1840 | 0.10 | Why? |
| Myography | 1 | 2008 | 6 | 0.10 | Why? |
| Tobacco Use Cessation | 1 | 2008 | 52 | 0.09 | Why? |
| Heart Rate | 1 | 2017 | 1527 | 0.09 | Why? |
| Public Policy | 1 | 2021 | 1894 | 0.09 | Why? |
| Anaphylaxis | 1 | 1998 | 940 | 0.09 | Why? |
| Parkinson Disease | 1 | 2020 | 1414 | 0.09 | Why? |
| Bronchodilator Agents | 1 | 2013 | 444 | 0.09 | Why? |
| Azathioprine | 1 | 2008 | 161 | 0.08 | Why? |
| Leukotrienes | 1 | 2007 | 37 | 0.08 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.08 | Why? |
| Antibodies, Antinuclear | 1 | 2008 | 234 | 0.08 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.08 | Why? |
| United States | 3 | 2018 | 46150 | 0.08 | Why? |
| Epithelial Cells | 1 | 2018 | 3508 | 0.08 | Why? |
| Antibodies, Monoclonal, Humanized | 2 | 2018 | 9335 | 0.08 | Why? |
| Respiratory System | 1 | 2018 | 3213 | 0.07 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2007 | 121 | 0.07 | Why? |
| Tacrolimus | 1 | 2008 | 435 | 0.07 | Why? |
| Adult | 7 | 2021 | 244371 | 0.07 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Syndrome | 1 | 2008 | 1310 | 0.06 | Why? |
| Risk Assessment | 2 | 2017 | 25439 | 0.06 | Why? |
| Influenza A Virus, H5N1 Subtype | 1 | 2007 | 492 | 0.06 | Why? |
| Respiration, Artificial | 1 | 2008 | 22116 | 0.06 | Why? |
| Surgeons | 1 | 2017 | 2233 | 0.06 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.06 | Why? |
| Counseling | 1 | 2008 | 747 | 0.06 | Why? |
| Female | 8 | 2021 | 380317 | 0.06 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2021 | 43792 | 0.06 | Why? |
| Adrenal Cortex Hormones | 3 | 2008 | 6537 | 0.06 | Why? |
| Double-Blind Method | 1 | 2013 | 5988 | 0.06 | Why? |
| Antibodies, Monoclonal | 2 | 2017 | 8041 | 0.06 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.06 | Why? |
| Budesonide | 1 | 2003 | 192 | 0.05 | Why? |
| Social Isolation | 1 | 2021 | 5932 | 0.05 | Why? |
| Male | 6 | 2021 | 367725 | 0.05 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Health Behavior | 1 | 2018 | 4449 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2018 | 17020 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.05 | Why? |
| Phobic Disorders | 1 | 2021 | 157 | 0.05 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.04 | Why? |
| Exercise | 1 | 2018 | 6771 | 0.04 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.04 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.04 | Why? |
| Rodentia | 1 | 2019 | 235 | 0.04 | Why? |
| Incidence | 1 | 2019 | 25622 | 0.04 | Why? |
| Aged | 4 | 2021 | 215776 | 0.04 | Why? |
| Global Health | 2 | 2019 | 13911 | 0.04 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.04 | Why? |
| Occupations | 1 | 2021 | 733 | 0.04 | Why? |
| Lower Extremity | 1 | 2020 | 593 | 0.04 | Why? |
| Time Factors | 1 | 2018 | 31397 | 0.04 | Why? |
| Patents as Topic | 1 | 2017 | 224 | 0.04 | Why? |
| Kinetics | 1 | 2003 | 3238 | 0.04 | Why? |
| Eosinophilia | 1 | 2018 | 292 | 0.03 | Why? |
| Clinical Trials as Topic | 1 | 2013 | 7330 | 0.03 | Why? |
| Treatment Outcome | 2 | 2018 | 51732 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2003 | 3776 | 0.03 | Why? |
| Antirheumatic Agents | 1 | 2008 | 3023 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Pediatrics | 1 | 2008 | 2969 | 0.03 | Why? |
| Genome-Wide Association Study | 1 | 2020 | 1648 | 0.03 | Why? |
| Drug Therapy, Combination | 1 | 2007 | 7268 | 0.03 | Why? |
| Communicable Diseases, Emerging | 1 | 2007 | 2523 | 0.03 | Why? |
| Sensitivity and Specificity | 1 | 2013 | 22971 | 0.03 | Why? |
| Drug Hypersensitivity | 1 | 1998 | 401 | 0.03 | Why? |
| Animals | 2 | 2019 | 78931 | 0.03 | Why? |
| Administration, Oral | 1 | 1998 | 2340 | 0.03 | Why? |
| Child | 2 | 2018 | 70012 | 0.03 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.03 | Why? |
| Research | 1 | 2003 | 2115 | 0.03 | Why? |
| Immunosuppressive Agents | 1 | 2008 | 6331 | 0.02 | Why? |
| Aspirin | 1 | 1998 | 1043 | 0.02 | Why? |
| Self Report | 1 | 2021 | 3802 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2003 | 7220 | 0.02 | Why? |
| Practice Guidelines as Topic | 3 | 2008 | 15421 | 0.02 | Why? |
| Risk Factors | 1 | 2017 | 71621 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2017 | 2483 | 0.02 | Why? |
| Retrospective Studies | 1 | 2018 | 105322 | 0.02 | Why? |
| Italy | 2 | 2021 | 38444 | 0.02 | Why? |
| SARS Virus | 1 | 2007 | 13021 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2007 | 12361 | 0.02 | Why? |
| Influenza, Human | 1 | 2007 | 10779 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2007 | 27595 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2017 | 10649 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Serologic Tests | 1 | 2007 | 4359 | 0.01 | Why? |
| Polymerase Chain Reaction | 1 | 2007 | 6740 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.01 | Why? |
| RNA, Viral | 1 | 2007 | 32276 | 0.00 | Why? |
| Antiviral Agents | 1 | 2007 | 41703 | 0.00 | Why? |
Polosa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_